Leading Pharmacy Law Plaintiffs’ Firm Gilman Law LLP Alerts Consumers to Recent Supreme Court Ruling Severely Limiting Their Rights in Defective Drug and Pharmaceutical Cases

PRWeb
Share
Wednesday, March 20th 2013
Advanced

Gilman Law LLP represents victims of drug side effects and medical device injuries, including those allegedly associated with Stryker Hip Implants, Biomet Hip Implants, the Da Vinci Surgical System, the Mirena IUD, GranuFlo and NaturaLyte Dialysis Drugs, and the Byetta diabetes medication.

Boston, MA (PRWEB) March 20, 2013

Leading pharmacy law and defective drugs plaintiffs’ law firm Gilman Law LLP is representing individuals in product liability claims involving defective drug side effects and dangerous medical devices, and is alerting consumers to recent and impending Supreme Court decisions that may greatly limit their rights to pursue compensation for any injuries caused by generic drug side effects. In 2011, the Supreme Court ruled in Pliva v. Mensing that federal law pre-empts state failure-to-warn laws that impose a duty or liability on generic drug makers to warn the public of dangerous side effects. The effect of the decision has prevented victims of generic drug injuries from pursuing failure-to-warn claims against generic drug manufacturers regardless of the merits of such a claim. [Pliva v. Mensing, 131 S. Ct. 2567 (2011)]

The defective drug and products liability law firm of Gilman Law LLP can provide a free legal consultation with no cost or obligation to individuals that have been injured by a defective drug or defective medical device. Contact our defective drug lawyers TOLL FREE at 888-252-0048 or submit a free legal consultation form online.

The Supreme Court’s Upcoming Decision May Limit Consumer Rights

On March 18th, the Supreme Court heard oral arguments in another generic drug case, Bartlett v. Mutual Pharm. Co., Inc. According to Ken Gilman of Gilman Law, LLP, "Depending on the Court’s decision in Bartlett, consumers could lose additional rights to recover for the victims of generic drug injuries." Unfortunately, most consumers are not aware of the Mensing or Bartlett decisions, or that they may not be able to recover for injuries against generic drug manufacturers according to Gilman Law. (Mutual Pharmaceutical Co. v. Bartlett, 12-142.)

In response to this news, Gilman Law continues to offer free case evaluations for the following drugs and medical devices:

  •     Stryker Hip Recall for Rejuvenate and ABG II Hip Stems
  •     Biomet M2a Magnum Hip Replacements
  •     Da Vinci Surgical System
  •     Mirena IUD
  •     GranuFlo and NaturaLyte Dialysis Drugs
  •     Byetta Diabetes Drug

About the Defective Drug and Medical Device Law Firm of Gilman Law LLP

The leading defective drug lawyers at Gilman Law LLP have been recognized for delivering successful results to their clients across a broad range of claims stemming from consumer product injury, mass tort, and class action lawsuits for over 34 years.

Contact:
Gilman Law LLP
Beachway Professional Center Tower
Suite 307
3301 Bonita Beach Road
Bonita Springs, FL 34134

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/3/prweb10554248.htm